The estimated Net Worth of Tim G. Guttman is at least 11.8 百万$ dollars as of 9 November 2018. Tim Guttman owns over 4,072 units of Amerisource Bergen stock worth over 9,948,395$ and over the last 13 years Tim sold ABC stock worth over 1,846,536$.
Tim has made over 15 trades of the Amerisource Bergen stock since 2014, according to the Form 4 filled with the SEC. Most recently Tim exercised 4,072 units of ABC stock worth 361,838$ on 9 November 2018.
The largest trade Tim's ever made was exercising 65,625 units of Amerisource Bergen stock on 18 February 2015 worth over 1,922,813$. On average, Tim trades about 7,315 units every 54 days since 2012. As of 9 November 2018 Tim still owns at least 55,275 units of Amerisource Bergen stock.
You can see the complete history of Tim Guttman stock trades at the bottom of the page.
Tim's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19087.
Over the last 21 years, insiders at Amerisource Bergen have traded over 4,389,593,610$ worth of Amerisource Bergen stock and bought 18,610 units worth 1,659,872$ . The most active insiders traders include Boots Alliance, Inc.Walgree...、Lon R Greenberg、Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of 13,111,903$. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth 813,987$.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: